2024 ICD-10-CM Diagnosis Code E70.39

Other specified albinism

ICD-10-CM Code:
E70.39
ICD-10 Code for:
Other specified albinism
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Endocrine, nutritional and metabolic diseases
    (E00–E89)
    • Metabolic disorders
      (E70-E88)
      • Disorders of aromatic amino-acid metabolism
        (E70)

E70.39 is a billable diagnosis code used to specify a medical diagnosis of other specified albinism. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Albinism-deafness syndrome of Tietz
  • Dystopia canthorum
  • Griscelli syndrome type 1
  • Griscelli syndrome type 3
  • Hypopigmentation-immunodeficiency disease
  • Hypopigmentation-immunodeficiency disease
  • Hypopigmentation-immunodeficiency disease
  • Immunodeficiency associated with multiple organ system abnormalities
  • Immunodeficiency associated with multiple organ system abnormalities
  • Immunodeficiency associated with multiple organ system abnormalities
  • Immunodeficiency with major anomalies
  • Immunodeficiency with major anomalies
  • Immunodeficiency with major anomalies
  • Phylloid hypomelanosis
  • Piebald trait with neurologic defects syndrome
  • Piebaldism
  • Profound hearing loss
  • Profound sensorineural hearing loss
  • Sensorineural hearing loss of bilateral ears
  • Waardenburg syndrome
  • Waardenburg syndrome type 3
  • Ziprkowski-Margolis syndrome

Clinical Classification

Clinical Information

  • Waardenburg Syndrome

    rare, autosomal dominant disease with variable penetrance and several known clinical types. characteristics may include depigmentation of the hair and skin, congenital deafness, heterochromia iridis, medial eyebrow hyperplasia, hypertrophy of the nasal root, and especially dystopia canthorum. the underlying cause may be defective development of the neural crest (neurocristopathy). waardenburg's syndrome may be closely related to piebaldism. klein-waardenburg syndrome refers to a disorder that also includes upper limb abnormalities.
  • Piebaldism

    autosomal dominant, congenital disorder characterized by localized hypomelanosis of the skin and hair. the most familiar feature is a white forelock presenting in 80 to 90 percent of the patients. the underlying defect is possibly related to the differentiation and migration of melanoblasts, as well as to defective development of the neural crest (neurocristopathy). piebaldism may be closely related to waardenburg syndrome.
  • Piebaldism

    a rare, autosomal dominant disorder caused usually by mutations in the kit gene. it is characterized by abnormalities in the development of melanocytes. it presents with multiple symmetrical hypopigmented or depigmented patches of skin and a midline patch of white hair.

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Piebaldism

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Convert E70.39 to ICD-9-CM

  • ICD-9-CM Code: 270.2 - Arom amin-acid metab NEC
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Patient Education


Skin Pigmentation Disorders

Pigmentation means coloring. Skin pigmentation disorders affect the color of your skin. Your skin gets its color from a pigment called melanin. Special cells in the skin make melanin. When these cells become damaged or unhealthy, it affects melanin production. Some pigmentation disorders affect just patches of skin. Others affect your entire body.

If your body makes too much melanin, your skin gets darker. Pregnancy, Addison's disease, and sun exposure all can make your skin darker. If your body makes too little melanin, your skin gets lighter. Vitiligo is a condition that causes patches of light skin. Albinism is a genetic condition affecting a person's skin. A person with albinism may have no color, lighter than normal skin color, or patchy missing skin color. Infections, blisters and burns can also cause lighter skin.


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.